Galventa: Funding, Investors & Team (Sep 2026)
Galventa mission is to develop, manufacture and market a compound with a release pattern based on micro pellets for use in the relieve of sleep inertia symptoms. Galventas break-through technology allows to establish a time-controlled pulsatile release system containing an Active Pharmaceutical Ingredient (API).
Galventa has raised $800k across 2 funding rounds on record, the most recent an undisclosed round announced in May 2023.
Galventa Company Profile and Key Stats
Latest funding round on record: May 2023.
Galventa Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Galventa raised $800k in a Seed announced in Sep 2021.
1.7 years later, an undisclosed round was announced in May 2023 with no disclosed amount.
Galventa Founders and Leadership Team
No contact details are on record for this team yet.
Galventa Funding Compared to Other Biotechnology Startups
Funded Startups Like Galventa in Biotechnology and Saint Gallen
Companies Similar to Galventa
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Galventa Funding FAQs
What does Galventa do?
Galventa mission is to develop, manufacture and market a compound with a release pattern based on micro pellets for use in the relieve of sleep inertia symptoms. Galventas break-through technology allows to establish a time-controlled pulsatile release system containing an Active Pharmaceutical Ingredient (API).
How much funding has Galventa raised?
Galventa has raised $800k across 2 rounds on record.
When did Galventa last raise funding?
Galventa's most recent funding round on record was announced in May 2023. The amount was not disclosed.
Who is the CEO of Galventa?
Sascha Fritsche is listed as CEO at Galventa.
Where is Galventa headquartered?
Galventa is based in Saint Gallen, Sankt Gallen, Switzerland.
How many employees does Galventa have?
Galventa is in the 1-10 employee band.
About FundedIQ's Galventa Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Galventa is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.